Contrasting to placebo, MIT treatment resulted in markedly reduced tumor sizes regardless of EREG expression in PSC27 cells, thus validating the efficacy of MIT as a cytotoxic agent (Fig. 6b and Supplementary Fig. 7c). This evidence concerns the gene EREG and neoplasm.